Calidi Biotherapeutics, Inc.
CLDI
$1.59
$0.053.25%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.63M | 5.60M | 10.38M | 5.28M | 10.56M |
| Total Receivables | -- | -- | -- | 50.00K | 50.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 484.00K | 422.00K | 385.00K | 377.00K | 596.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 238.00K | 234.00K | 268.00K | 343.00K | 282.00K |
| Total Current Assets | 7.35M | 6.26M | 11.03M | 6.05M | 11.49M |
|
|
|||||
| Total Current Assets | 7.35M | 6.26M | 11.03M | 6.05M | 11.49M |
| Net Property, Plant & Equipment | 2.10M | 2.46M | 2.86M | 3.26M | 3.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 138.00K | 138.00K | 140.00K | 40.00K | 144.00K |
| Total Assets | 9.59M | 8.86M | 14.03M | 9.35M | 15.06M |
|
|
|||||
| Total Accounts Payable | 900.00K | 613.00K | 1.15M | 1.23M | 1.21M |
| Total Accrued Expenses | 1.43M | 1.81M | 2.17M | 1.93M | 1.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.50M | 1.52M | 1.87M | 2.19M | 2.45M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.84M | 3.94M | 5.19M | 5.35M | 5.43M |
|
|
|||||
| Total Current Liabilities | 3.84M | 3.94M | 5.19M | 5.35M | 5.43M |
| Long-Term Debt | 600.00K | 600.00K | 600.00K | 600.00K | 600.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 153.00K | 448.00K | 837.00K | 1.22M | 1.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 67.00K | 115.00K | 201.00K | 103.00K | 87.00K |
| Total Liabilities | 4.66M | 5.10M | 6.83M | 7.28M | 7.77M |
|
|
|||||
| Common Stock & APIC | 150.69M | 145.39M | 144.50M | 134.19M | 133.67M |
| Retained Earnings | -145.73M | -141.62M | -137.57M | -132.42M | -126.70M |
| Treasury Stock & Other | -22.00K | -13.00K | -13.00K | -13.00K | -26.00K |
| Total Common Equity | 4.94M | 3.76M | 6.92M | 1.76M | 6.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.94M | 3.76M | 6.92M | 1.76M | 6.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | 280.00K | 312.00K | 358.00K |
| Total Equity | 4.94M | 3.76M | 7.20M | 2.08M | 7.30M |
|
|
|||||